Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 ×
				Submit


Vital Signs


Section Navigation
			
			CDC Home








View All Topics
 View All Topics


Related Pages
										Updated Mar. 14, 2023 | Print300xThe number of people on lifesaving HIV treatment through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) increased 300 times from just 66,500 individuals in 2004 to over 20 million people in 2022.95%The percent of people with HIV on PEPFAR-supported treatment worldwide with a viral load test that were virally suppressed* increased from 80% in 2015 to 95% in 2022.
*Virally suppressed refers to people who, thanks to treatment, have their virus under control. This can prevent transmission of HIV to sexual partners and helps reduce the risk of transmission from mothers to children.62%CDC supports the majority (62%) of people receiving lifesaving antiretroviral therapy† through PEPFAR.
†Antiretroviral therapy (ART) is treatment for HIV.Overview
The U.S. President’s Emergency Plan for AIDS Relief, or PEPFAR, was announced in 2003. One year later, PEPFAR began efforts to expand treatment for people with HIV. Effective HIV treatment helps those with HIV live longer, healthier lives. It can prevent transmission of the virus to sexual partners and helps reduce the risk of transmission from mothers to children. This, in turn, reduces new infections overall. As a result, increasing access to effective HIV treatment is critical to efforts to eliminate HIV as a global public health threat.
Since 2004, PEPFAR’s efforts to scale up HIV treatment have transformed the global HIV epidemic and saved millions of lives. The number of people with HIV receiving lifesaving treatment through PEPFAR increased an astonishing 300 times from just 66,500 people in 2004 to more than 20 million people in 2022.
Between 2015 and 2022, the percentage of people receiving HIV treatment through PEPFAR who had a viral load test and were virally suppressed also increased from 80% to 95%. Virally suppressed refers to people who, thanks to treatment, have their virus under control.
When it was launched, PEPFAR became the largest commitment by any nation to address a single disease in history. At the time, HIV was a global crisis, devastating families, communities, and economies worldwide—particularly in sub-Saharan African countries.
In many countries around the world, lack of access to lifesaving HIV treatment and weak health systems meant that an HIV diagnosis almost certainly led to death.
As the lead public health agency of PEPFAR, CDC plays a critical role in fighting the global HIV epidemic in more than 50 countries. CDC brings more than 30 years’ experience and a combination of scientific and technical expertise to bear in the fight against one of the world’s deadliest infectious diseases. In fact, today, CDC and its governmental and non-governmental partners support the majority (62%) of all people on PEPFAR-supported HIV treatment.
PEPFAR’s work to strengthen health systems around the globe is also helping countries respond not only to HIV but to other public health crises, such as COVID-19, improving our overall global health security. CDC has been at the forefront of these efforts, maximizing our long-standing relationships with ministries of health and local partners, strengthening laboratory systems, training and supporting health care workers, and enhancing disease monitoring systems as part of PEPFAR. As a result, these efforts are helping countries respond to their HIV epidemics while also preparing them for future health threats.
Moving forward, as part of PEPFAR’s five-year strategy, the United States aims to eliminate HIV as a global public health threat by 2030. This work is far from done.
To achieve this 2030 goal, the global health community must:
Sustain efforts to drive down new HIV infections and deaths among all affected populations,
Reduce inequities that prevent access to lifesaving HIV services, and
Strengthen the public health systems that help make the world a safer place for us all.Read the full *MMWR*ASL video: English | SpanishChallengesshield icon
Specific populations continue to be left behind.blue shapeAdvance Health Equityscales icon
End inequities that prevent access to lifesaving HIV treatment and prevention services.blue shapeEnd the Global HIV Epidemichand holding lightbulb icon
Building on PEPFAR’s achievements will allow us to eliminate HIV and strengthen global health security.blue shapeChallengesshield icon
Specific populations continue to be left behind.blue shapeAdvance Health Equityscales icon
End inequities that prevent access to lifesaving HIV treatment and prevention services.blue shapeEnd the Global HIV Epidemichand holding lightbulb icon
Building on PEPFAR’s achievements will allow us to eliminate HIV and strengthen global health security.blue shapeOverview
The U.S. President’s Emergency Plan for AIDS Relief, or PEPFAR, was announced in 2003. One year later, PEPFAR began efforts to expand treatment for people with HIV. Effective HIV treatment helps those with HIV live longer, healthier lives. It can prevent transmission of the virus to sexual partners and helps reduce the risk of transmission from mothers to children. This, in turn, reduces new infections overall. As a result, increasing access to effective HIV treatment is critical to efforts to eliminate HIV as a global public health threat.
Since 2004, PEPFAR’s efforts to scale up HIV treatment have transformed the global HIV epidemic and saved millions of lives. The number of people with HIV receiving lifesaving treatment through PEPFAR increased an astonishing 300 times from just 66,500 people in 2004 to more than 20 million people in 2022.
Between 2016 and 2022, the percentage of people receiving HIV treatment through PEPFAR who had a viral load test and were virally suppressed also increased from 80% to 95%. Virally suppressed refers to people who, thanks to treatment, have their virus under control.
When it was launched, PEPFAR became the largest commitment by any nation to address a single disease in history. At the time, HIV was a global crisis, devastating families, communities, and economies worldwide—particularly in sub-Saharan African countries.
In many countries around the world, lack of access to lifesaving HIV treatment and weak health systems meant that an HIV diagnosis almost certainly led to death.
As the lead public health agency of PEPFAR, CDC plays a critical role in fighting the global HIV epidemic in more than 50 countries. CDC brings more than 30 years’ experience and a combination of scientific and technical expertise to bear in the fight against one of the world’s deadliest infectious diseases. In fact, today, CDC and its governmental and non-governmental partners support the majority (62%) of all people on PEPFAR-supported HIV treatment.
PEPFAR’s work to strengthen health systems around the globe is also helping countries respond not only to HIV but to other public health crises, such as COVID-19, improving our overall global health security. CDC has been at the forefront of these efforts, maximizing our long-standing relationships with ministries of health and local partners, strengthening laboratory systems, training and supporting health care workers, and enhancing disease monitoring systems as part of PEPFAR. As a result, these efforts are helping countries respond to their HIV epidemics while also preparing them for future health threats.
Moving forward, as part of PEPFAR’s five-year strategy, the United States aims to eliminate HIV as a global public health threat by 2030. This work is far from done.
To achieve this 2030 goal, the global health community must:
Sustain efforts to drive down new HIV infections and deaths among all affected populations,
Reduce inequities that prevent access to lifesaving HIV services, and
Strengthen the public health systems that help make the world a safer place for us all.Read the full *MMWR*ASL video: English | SpanishChallengeslarge shield icon
**Gaps remain**: Despite tremendous achievements over the past 20 years, significant gaps remain.
**Continued inequities**: Today, people from certain groups, including youth, men, and several key populations, have been and continue to be left behind because of health inequities.
The report shows that while viral load suppression rates have reached 95% overall, certain groups—including individuals who are pregnant and breastfeeding, children, adolescents, and people living in prisons—have yet to achieve comparable rates.The data also show population viral load suppression rates were lower in men when compared to women and lower in younger people when compared to older people.More than 20 Million People Have Received HIV Treatment through PEPFAR
The number of people on lifesaving HIV treatment through PEPFAR increased 300 times since 2004.
View Larger
Close
Infographic showing more than 20 million people have received HIV treatment through PEPFAR (President’s Emergency Plan for AIDS Relief)Number of people globally
2004: 66,500
2022: 20 million+
300 times increase from 2004 to 2022
Download Image[PNG]Sustaining PEPFAR’s Global Gains in HIV Treatment Requires Tremendous Effort
The percent of people with HIV on PEPFAR-supported treatment who were virally suppressed rose from 80% in 2015 to 95% in 2022.
View Larger
Close
Infographic about sustaining PEPFAR’s global gains in HIV treatmentHIV Viral Suppression* Rates
2015: 80%
2022: 95%
*Viral suppression refers to having the virus under control thanks to treatment
Download Image[PNG]CDC Is at the Forefront of Strengthening Health Systems Globally
PEPFAR’s HIV efforts are strengthening health systems around the world, which helps countries confront other health threats and protects Americans at home and abroad. CDC plays a critical role.
View Larger
Close
Infographic 3CDC leading PEPFAR’s efforts to strengthen health systems
PEPFAR
Health Care
Training health care workforce
Laboratory
Strengthening lab systems
Monitoring
Enhancing monitoring
Partnerships
Fostering partnerships
Download Image[PNG]**What Can Be Done**To Advance Health EquityAddress health inequities in HIV treatment and prevention—a core principle of PEPFAR since it began.
Expand access to HIV treatment and prevention for communities particularly affected by HIV due to many factors, including stigma and discrimination.
These include key populations, such as gay and bisexual men, female sex workers, people who inject drugs, people living in prisons, and transgender people, primarily transgender women.
Understand and tackle the roots of health disparities—including stigma, discrimination, and social inequities that create barriers to accessing lifesaving HIV treatment and prevention services. This is key to eliminating HIV as a global public health threat.Photo collage of people being educated, a person being handed medicine, a boy smiling, and a mother holding an infant while they are being examined.
Photos: Thom Pierce 2018Address health inequities in HIV treatment and prevention—a core principle of PEPFAR since it began.
Expand access to HIV treatment and prevention for communities particularly affected by HIV because of many factors, including stigma and discrimination.
These include key populations, such as gay and bisexual men, female sex workers, people who inject drugs, people living in prisons, and transgender people, primarily transgender women.
Understand and tackle the roots of health disparities—including stigma, discrimination, and social inequities that create barriers to accessing lifesaving HIV treatment and prevention services. This is key to eliminating HIV as a global public health threat.
Photo collage of people being educated, a person being handed medicine, a boy smiling, and a mother holding an infant while they are being examined.
Photos: Thom Pierce 2018To End the Global HIV EpidemicContinue to build on 20 years of achievements
We’ve come a long way in the fight against HIV. Twenty years ago, when PEPFAR was launched, an HIV diagnosis in many countries almost certainly meant death and, globally, communities were being devastated by HIV.
When PEPFAR began, only 50,000 people in Africa were on HIV treatment. Today, more than 20 million men, women, and children are on PEPFAR-supported treatment. PEPFAR investments are managing a chronic disease at an unprecedented scale. By providing effective treatment, these investments are helping to drive down new HIV infections and deaths—putting the world on the path to eliminate HIV as a global public health threat by 2030.Leverage lessons learned from PEPFAR’s successes
A few examples of PEPFAR’s impact in partner countries include:
In Uganda, one of the first countries supported by PEPFAR, efforts to expand lifesaving HIV treatment have prevented over 600,000 deaths related to HIV and nearly half a million HIV infections since 2004.
In just five years (from 2011–2016), Eswatini’s rate of new HIV infections was cut nearly in half and its national rate of HIV viral load suppression was doubled.
In Nigeria, the number of people newly diagnosed with HIV who began HIV treatment increased eightfold in just 18 months—even in the midst of the COVID-19 pandemic.Sustain impact
Despite these tremendous achievements, the fight against HIV is far from over. At the end of 2021, almost 15% of people living with HIV did not know their HIV status. Nearly 10 million people with HIV were not accessing lifesaving treatment and 1.5 million people had newly acquired an HIV infection.
Eliminating HIV as a global public health threat is within our grasp. To achieve this goal by 2030, as outlined by PEPFAR’s new five-year strategy, we must stay the course and build on our progress to date. As a global health community, we must:
**Sustain HIV efforts and investments**: Continue to be unrelenting in our efforts to build on these achievements or risk reversing decades of progress. Invest in patient-centered, data-driven programs, and expand the innovations and tools that are proven to effectively drive down new HIV infections and deaths.
**Advance health equity**: Address health inequities head on. Build on our existing work to strengthen efforts to reach populations that continue to be left behind. Address the disparities that prevent too many from accessing lifesaving HIV treatment and prevention services.
**Strengthen health systems**: Continue to bolster and use PEPFAR platforms to strengthen global health security. PEPFAR has worked to strengthen public health systems—from improving laboratories and disease monitoring systems to training healthcare workers—in countries around the globe. These efforts have proved vital in responding to other public health threats, such as COVID-19. PEPFAR’s investments in strengthening these health systems will help to confront future health threats—and protect the health of Americans at home and around the world.
**Build transformative partnerships**: Collaborate and harness our shared commitment to bring an end to the global HIV epidemic.It will take collective effort—governments, policy makers, and public health advocates, communities and patients, public health and private enterprise—working together to continue the momentum. By doing so, we can eliminate HIV as a global health threat, continue to save lives, and strengthen the public health systems that make the world a safer place.Footnotes and References
	**Footnotes**
*Virally suppressed refers to people who, thanks to treatment, have their virus under control. This can prevent transmission of HIV to sexual partners and helps reduce the risk of transmission from mothers to children.
†Antiretroviral therapy (ART) is treatment for HIV.
**Related Pages and Resources**
*Vital Signs:* Media Statement – U.S.-Led Global Effort Dramatically Increases Number of People Receiving Lifesaving HIV Treatment in Less than Two Decades [English]
*Vital Signs:* Media Statement – Iniciativa global liderada por los Estados Unidos aumenta significativamente la cantidad de personas que reciben tratamiento contra el VIH que salva vidas, en menos de dos décadas [Spanish]
*Morbidity and Mortality Weekly Report (MMWR):* *Vital Signs*: Progress Toward Eliminating HIV as a Global Public Health Threat through Scale-Up of Antiretroviral Therapy and Health System Strengthening Supported by the U.S. President’s Emergency Plan for AIDS Relief—Worldwide, 2004–2022
Faces From the Frontlines
CDC’s Division of Global HIV and TB
CDC’s Global HIV Impact
DGHT HIV Overview Fact Sheet [4.6 MB, 2 pages]email_03Vital Signs Update	Get email updates about Vital Signs		Email Address			What's this?				Submit**VITAL SIGNS RESOURCES**
Digital Media Tools
							
					
			Last Updated Mar. 14, 2023														Source: 	Office of the Associate Director for Communication
					Facebook
        Twitter
        LinkedIn
        Syndicate homeVital Signs
Topics Covered
Digital Media Tools


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue